Skip to content
Open access

Tumor-derived SAA1-TLR4 signaling drives tumor-to-muscle communication in pancreatic cancer cachexia

Sep 2026 · bioRxiv · 0 citations
Biology Medicine

TL;DR

Conservation of SAA1-TLR4 signaling in human skeletal muscle identifies a therapeutically actionable tumor–host pathway and demonstrates that host deterioration can be targeted independently of tumor progression.

Read PDF

Similar papers

Sep 2026

Abstract B101: Stroma-tumor crosstalk converges with oncogenic KRAS signaling to drive an NFκB-mediated immune evasion program

An immunosuppressive tumor microenvironment (TME) is a hallmark of pancreatic ductal adenocarcinoma (PDAC), rendering most tumors resistant to immunotherapy approaches. Importantly, “tumor-to-stroma” crosstalk downstream of oncogenic KRAS has emerged as a major driver of immune evasion in PDAC, however the role of re...

Yuwenbin Li, M. Truitt, Dan Cao et al. · 0 citations
Sep 2026

Abstract B001: Cancer-associated fibroblast p38α MAPK signaling coordinates collagen architecture and immune suppression to drive chemoresistance in pancreatic cancer

This work identified p38α MAPK (p38α; MAPK14) as a key regulator of inflammatory CAF activation and collagen remodeling and implicates it as a central mediator of stromal remodeling and therapeutic resistance in pancreatic cancer.

C. Acevedo, Sayan Chakraborty, Samara P. Singh et al. · 0 citations
Sep 2026

Abstract B099: Tumor progression locus 2 kinase drives pancreatic cancer immune evasion through a MYBL2-CXCL10 signaling axis

Findings identify a previously unrecognized tumor-intrinsic TPL2-MYBL2-CXCL10 signaling axis that promotes immune evasion and targets TPL2-targeted therapies in PDAC, providing strong rationale for clinical development of TPL2-targeted therapies in PDAC.

Hua-Ping Li, Yu-Tong Geng, Hung-Han Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.